A Potential Anticancer Agent 1,2-di(quinazolin-4-yl)diselane

ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)

Volume 12, 10 Issues, 2015

Download PDF Flyer

Letters in Drug Design & Discovery

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Email: lddd@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 0.770
5 - Year: 0.757

A Potential Anticancer Agent 1,2-di(quinazolin-4-yl)diselane

Letters in Drug Design & Discovery, 11(6): 731-735.

Author(s): Yinjiu Huang, Gang Liu, Xiaomei Hu, Hao Liu, Jianguo Hu, Zhenzhong Feng, Bi Tang, Jun Qian, Qiyi Wang and Xuehui Long.

Affiliation: School of Chemistry and Materials Science, Ludong University, Yantai 264025, PR China.


The development of antitumor drugs with novel effects is urgent for cancer patients. In our recent anticancer drug discovery study, 1,2-di(quinazolin-4-yl)diselane (LG003) was synthesized and showed considerable antitumor effects on six tested cancer cell lines in vitro. Morphological observation and Lactate Dehydrogenase release assay revealed that LG003 exerted such effect in A549 cells through antiproliferation, apoptosis or other pathway rather than cytotoxicity which suggests that compound LG003 is a potential antitumor agent.


1, 2-di(quinazolin-4-yl)diselane, Anticancer activity, Cytotoxicity, A549, Anticancer agent, Breast cancer.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 6
First Page: 731
Last Page: 735
Page Count: 5
DOI: 10.2174/1570180811666140214204858

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science